Primary and Rescue Percutaneous Coronary Intervention With Paclitaxel-Eluting Stent Implantation in ST-Elevation Myocardial Infarction

American Journal of Cardiology

Volumn 97, Issue 9, 2006, Pages 1308-1310

  Schwalm, Jon David Reid ^a   Ahmad, Mayraj ^a   Velianou, James L ^a   Xie, Changchun ^a   Natarajan, Madhu K ^a  

^a HAMILTON GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY STENT; CORRELATION ANALYSIS; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; METAL IMPLANTATION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RECURRENT DISEASE; ST SEGMENT ELEVATION; THROMBOSIS; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CANADA; CORONARY THROMBOSIS; DRUG DELIVERY SYSTEMS; ELECTROCARDIOGRAPHY; FEMALE; HOSPITAL MORTALITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PACLITAXEL; RETROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME;

EID: 33646065658     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.11.071     Document Type: Article

References (8)

1. Holmes Jr. D.R., Leon M.B., Moses J.W., Popma J.J., Cutlip D., Fitzgerald P.J., Brown C., Fischell T., Wong S.C., Midei M., et al. Analysis of 1-year clinical outcomes in the SIRIUS trial. a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation 109 (2004) 634-640
2. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Caputo R., Bergin P., Greenberg J., Popma J.J., and Russell M.E. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent. the TAXUS-IV trial. Circulation 109 (2004) 1942-1947
3. Moses J.W., Mehran R., Nikolsky E., Lasala J.M., Corey W., Albin G., Hirsh C., Leon M.B., Russell M.E., Ellis S.G., and Stone G.W. Outcome with paclitaxel-eluting stent in patients with acute coronary syndromes. Analysis from the TAXUS IV trial. J Am Coll Cardiol 45 (2005) 1165-1171
4. Lemos P.A., Saia F., Hofma S.H., Daemen J., Ong A.T., Arampatzis C.A., Hoye A., McFadden E., Sianos G., Smits P.C., et al. Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction. J Am Coll Cardiol 43 (2004) 704-708
5. Valgimigli M., Percoco G., Malagutti P., Campo G., Ferrari F., Barbieri D., Cicchitelli G., McFadden E.P., Merlini F., Ansani L., et al. Tirofiban and sirolimus-eluting stent versus abciximab and bare-metal stent for acute myocardial infarction. A randomized trial. JAMA 293 (2005) 2109-2117
6. Antman E.M., Anbe D.T., Armstrong P.W., Bates E.R., Green L.A., Hand M., Hochman J.S., Krumholz H.M., Kushner F.G., Lamas G.A., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary. A report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol 44 (2004) 671-719
7. Keeley E.C., Boura J.A., and Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction. a quantitative review of 23 randomized trials. Lancet 361 (2003) 13-20
8. Hofma S.H., Ong A.T., Aoki J., Van Mieghem C.A., Rodriguez Granillo G.A., Valgimigli M., Regar E., De Jaegere P.P., McFadden E.P., Sianos G., et al. One-year clinical follow-up of paclitaxel-eluting stents for acute myocardial infarction compared to sirolimus-eluting stents. Heart 91 (2005) 1176-1180